Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Metaxas C, Mathis D, Jeger C et al (2017) Early biomarker response and patient preferences to oral and intramuscular Vitamin B12 substitution in primary care: a randomized parallel-group trial
Sermorelin (10mg) Description A single-component research material supplied for controlled research environments
TOP Key Recommendations Routine B 12 screening and testing in asymptomatic patients is not supported by evidence
the FDA has stated it lacks sufficient information to know whether the substance would cause harm when administered to humans Evidence snapshot: The evidence base is almost entirely preclinical, decades of animal (largely rat) studies, mostly from one Croatian research group (Sikiric et al., University of Zagreb), with a single small human trial under the brand name "Bepecin" (around 2015) that did not lead to any FDA-approved use
US$ 21.95
US$ 21.23
US$ 20.31
US$ 21.86
US$ 28.97
